lunes, 16 de noviembre de 2026
Bladder cancer immunotherapy from CG Oncology reduced risk of tumor recurrence The study results could change the way physicians treat certain patients with bladder cancer
https://www.statnews.com/2026/11/16/bladder-cancer-immunotherapy-reduced-tumor-recurrence-cg-oncology/
By Adam FeuersteinNov. 16, 2026
Adam Feuerstein, a senior writer and biotech columnist, is the author of Adam’s Biotech Scorecard, a subscriber-only newsletter about the crossroads of drug development, business, Wall Street, and biotechnology.
Suscribirse a:
Enviar comentarios (Atom)


No hay comentarios:
Publicar un comentario